MedPath

Effects of metformin and lifestyle modifications on the progression of the atherosclerosis among individuals with impaired glucose tolerance

Phase 3
Recruiting
Conditions
Pre-diabetes
Registration Number
SLCTR/2016/026
Lead Sponsor
niversity Grants Commission, Sri Lanka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Intervention groups

1.Males and females aged > 20 years

2.Oral Glucose Tolerance Test (OGTT) 2 hrs value: between 140 and 199 mg/dl

Reference group

1.Males and females aged > 20 years

2.Oral Glucose Tolerance Test (OGTT) 2 hrs value: < 140 mg/dL

Exclusion Criteria

1. Pregnancy
2. Diagnosed diabetes mellitus or diagnosed by screening test OGTT 2 hr value: > 200 mg/dL
3. Manifested vascular disease such as ischemic heart disease, peripheral vascular disease or cerebrovascular disease
4. Patients already on drugs to modify the vascular risk factors, Eg: • anti-platelets • anti anginals • statins or lipid lowering drugs • folic acid • anti-inflammatory drugs • anticoagulants

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.